BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9835957)

  • 1. [Impetigo in French Guyana. A clinical, bacteriological, toxicological and sensitivity to antibiotics study].
    Couppié P; Sainte-Marie D; Prévost G; Gravet A; Clyti E; Moreau B; Monteil H; Pradinaud R
    Ann Dermatol Venereol; 1998 Oct; 125(10):688-93. PubMed ID: 9835957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
    Bernard P; Jarlier V; Santerre-Henriksen A
    Ann Dermatol Venereol; 2008 Jan; 135(1):13-9. PubMed ID: 18342068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.
    Alsterholm M; Flytström I; Bergbrant IM; Faergemann J
    Acta Derm Venereol; 2010; 90(1):52-7. PubMed ID: 20107726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contagious impetigo--pathogen spectrum and therapeutic consequences].
    Abeck D; Mempel M; Seidl HP; Schnopp C; Ring J; Heeg K
    Dtsch Med Wochenschr; 2000 Oct; 125(42):1257-9. PubMed ID: 11098236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An epidemic of bullous impetigo in the municipality of Austevoll in the year 2002].
    Rørtveit S; Rørtveit G
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2557-60. PubMed ID: 14714041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pristinamycin versus oxacillin in the treatment of superficial pyoderma. A multicenter randomized study in 293 outpatients].
    Bernard P; Vaillant L; Martin C; Beylot C; Quentin R; Touron D
    Ann Dermatol Venereol; 1997; 124(5):384-9. PubMed ID: 9739895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial skin infections at a tertiary dermatological centre.
    Tan HH; Tay YK; Goh CL
    Singapore Med J; 1998 Aug; 39(8):353-6. PubMed ID: 9844495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Managing children skin and soft tissue infections].
    Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impetigo in epidemic and nonepidemic phases: an incidence study over 4(1/2) years in a general population.
    Rørtveit S; Rortveit G
    Br J Dermatol; 2007 Jul; 157(1):100-5. PubMed ID: 17553056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of impetigo.
    Cole C; Gazewood J
    Am Fam Physician; 2007 Mar; 75(6):859-64. PubMed ID: 17390597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy of josamycin in the treatment of impetigo in children and its in vitro activity on erythromycin resistant Staphylococcus aureus strains.
    Mosca A; Del Prete R; Mazzotta F; Bonifazi E; Miragliotta G
    J Chemother; 1995 Nov; 7 Suppl 4():158-9. PubMed ID: 8904141
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel antibacterial activity of monolaurin compared with conventional antibiotics against organisms from skin infections: an in vitro study.
    Carpo BG; Verallo-Rowell VM; Kabara J
    J Drugs Dermatol; 2007 Oct; 6(10):991-8. PubMed ID: 17966176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo.
    Durupt F; Mayor L; Bes M; Reverdy ME; Vandenesch F; Thomas L; Etienne J
    Br J Dermatol; 2007 Dec; 157(6):1161-7. PubMed ID: 17916211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use.
    Weston VC; Boswell TC; Finch RG; Perkins W
    BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053928
    [No Abstract]   [Full Text] [Related]  

  • 15. Fusidic acid cream for impetigo. Resistance trends must be monitored.
    Zadik P; Young N
    BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053930
    [No Abstract]   [Full Text] [Related]  

  • 16. Fusidic acid cream for impetigo. Judicious use is advisable.
    Sule O; Brown N; Brown DF; Burrows N
    BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053927
    [No Abstract]   [Full Text] [Related]  

  • 17. Fusidic acid cream for impetigo. Findings cannot be extrapolated.
    Owen SE; Cheesbrough JS
    BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053931
    [No Abstract]   [Full Text] [Related]  

  • 18. Fusidic acid cream for impetigo. Problem may be clinically important.
    Stoddart B; Collyns T; Denton M
    BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053929
    [No Abstract]   [Full Text] [Related]  

  • 19. High levels of fusidic acid-resistant Staphylococcus aureus despite restrictions on antibiotic use.
    Mitra A; Mohanraj M; Shah M
    Clin Exp Dermatol; 2009 Mar; 34(2):136-9. PubMed ID: 18828847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
    Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J
    Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.